 Jose Diaz-Miron
Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestine, Small | 8 | 2017 | 155 | 1.470 |
Why?
| | Adaptation, Physiological | 6 | 2017 | 530 | 0.830 |
Why?
| | Neovascularization, Physiologic | 3 | 2015 | 197 | 0.680 |
Why?
| | Short Bowel Syndrome | 5 | 2017 | 23 | 0.650 |
Why?
| | Coronary Aneurysm | 1 | 2014 | 15 | 0.580 |
Why?
| | Thoracic Injuries | 1 | 2014 | 53 | 0.550 |
Why?
| | Baseball | 1 | 2014 | 47 | 0.540 |
Why?
| | Hemostasis | 1 | 2013 | 62 | 0.540 |
Why?
| | Aneurysm, Dissecting | 1 | 2014 | 88 | 0.520 |
Why?
| | Hematopoiesis | 1 | 2013 | 178 | 0.500 |
Why?
| | Wounds, Nonpenetrating | 1 | 2014 | 257 | 0.450 |
Why?
| | Intestinal Mucosa | 5 | 2017 | 510 | 0.380 |
Why?
| | Receptor, IGF Type 1 | 2 | 2017 | 58 | 0.320 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2017 | 23 | 0.320 |
Why?
| | Retinoblastoma Protein | 2 | 2017 | 55 | 0.320 |
Why?
| | Chemokine CXCL5 | 2 | 2015 | 14 | 0.300 |
Why?
| | Infant, Newborn | 1 | 2013 | 4858 | 0.260 |
Why?
| | Neuroblastoma | 2 | 2011 | 136 | 0.200 |
Why?
| | Mice, Knockout | 5 | 2017 | 2886 | 0.180 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 5127 | 0.160 |
Why?
| | Enterocytes | 1 | 2014 | 18 | 0.150 |
Why?
| | Intestinal Absorption | 1 | 2015 | 115 | 0.150 |
Why?
| | Vitamin K Deficiency Bleeding | 1 | 2013 | 2 | 0.140 |
Why?
| | Extracorporeal Circulation | 1 | 2013 | 18 | 0.140 |
Why?
| | Dietary Proteins | 1 | 2014 | 125 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 96 | 0.140 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2013 | 32 | 0.140 |
Why?
| | Intracranial Hemorrhages | 1 | 2013 | 68 | 0.130 |
Why?
| | Body Composition | 2 | 2014 | 737 | 0.130 |
Why?
| | Diet, High-Fat | 1 | 2014 | 241 | 0.120 |
Why?
| | ErbB Receptors | 1 | 2015 | 509 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 58 | 0.110 |
Why?
| | Weight Gain | 1 | 2014 | 486 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2017 | 372 | 0.100 |
Why?
| | Imidazoles | 1 | 2011 | 264 | 0.100 |
Why?
| | Angiogenesis Inhibitors | 1 | 2011 | 218 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2011 | 283 | 0.100 |
Why?
| | Microbiota | 1 | 2014 | 460 | 0.100 |
Why?
| | Piperazines | 1 | 2011 | 308 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 500 | 0.090 |
Why?
| | Bacteria | 1 | 2014 | 642 | 0.090 |
Why?
| | Animals | 9 | 2017 | 34608 | 0.090 |
Why?
| | RNA | 1 | 2014 | 762 | 0.090 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 598 | 0.080 |
Why?
| | Mice | 7 | 2017 | 14934 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 439 | 0.080 |
Why?
| | Postoperative Period | 2 | 2017 | 305 | 0.070 |
Why?
| | Disease Models, Animal | 4 | 2014 | 3843 | 0.070 |
Why?
| | Random Allocation | 2 | 2014 | 400 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2599 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2009 | 1061 | 0.060 |
Why?
| | Cell Proliferation | 3 | 2015 | 2342 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1845 | 0.050 |
Why?
| | Humans | 5 | 2014 | 109171 | 0.040 |
Why?
| | Male | 4 | 2014 | 60174 | 0.040 |
Why?
| | Adolescent | 1 | 2014 | 18208 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2014 | 2885 | 0.040 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 11 | 0.040 |
Why?
| | Sodium-Glucose Transporter 1 | 1 | 2014 | 12 | 0.040 |
Why?
| | Fish Oils | 1 | 2014 | 29 | 0.040 |
Why?
| | Apoptosis | 2 | 2015 | 2560 | 0.040 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 64 | 0.040 |
Why?
| | Tamoxifen | 1 | 2014 | 183 | 0.030 |
Why?
| | Microcirculation | 1 | 2014 | 156 | 0.030 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 123 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 2014 | 140 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 2837 | 0.030 |
Why?
| | Linear Models | 1 | 2014 | 905 | 0.030 |
Why?
| | Blotting, Western | 1 | 2014 | 1342 | 0.030 |
Why?
| | Bevacizumab | 1 | 2011 | 126 | 0.030 |
Why?
| | Energy Intake | 1 | 2014 | 487 | 0.030 |
Why?
| | Up-Regulation | 1 | 2014 | 958 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 245 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 673 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 156 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 190 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 176 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1000 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 613 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 755 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 681 | 0.020 |
Why?
| | Weight Loss | 1 | 2014 | 754 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 448 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 982 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 3365 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1156 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4830 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2327 | 0.020 |
Why?
| | Computational Biology | 1 | 2009 | 649 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 1718 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 3119 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2014 | 2097 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2009 | 4343 | 0.010 |
Why?
| | Female | 1 | 2014 | 61606 | 0.010 |
Why?
|
|
Diaz-Miron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|